Stallergenes Greer Ltd
Stallergenes Greer Ltd, a leading player in the immunotherapy industry, is headquartered in Great Britain and operates extensively across Europe and North America. Founded in 2014 through the merger of Stallergenes and Greer Laboratories, the company has quickly established itself as a pioneer in allergy treatment solutions. Specialising in allergen immunotherapy, Stallergenes Greer offers a range of innovative products, including sublingual and injectable therapies, designed to provide long-term relief from allergic conditions. Their commitment to research and development has led to significant advancements in personalised treatment options, setting them apart in a competitive market. With a strong focus on patient-centric care, Stallergenes Greer Ltd has achieved notable recognition for its contributions to allergy management, solidifying its position as a trusted name in the field.
DitchCarbon Score
How does Stallergenes Greer Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Stallergenes Greer Ltd's score of 18 is lower than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Stallergenes Greer Ltd's reported carbon emissions
Stallergenes Greer Ltd, headquartered in Great Britain, currently does not have publicly available carbon emissions data for the most recent year, nor do they have specified reduction targets or initiatives documented. Without specific emissions figures or commitments, it is challenging to assess their climate impact or sustainability efforts. However, the company is likely to be engaged in industry-standard practices aimed at reducing carbon footprints, aligning with broader climate commitments prevalent in the pharmaceutical and biotechnology sectors. As the landscape of corporate climate responsibility evolves, Stallergenes Greer Ltd may develop and disclose future targets and initiatives to enhance their environmental performance.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Stallergenes Greer Ltd is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
